Online Health Survey of Patients With Vitiligo Vulgaris/ Online Survey of Pediatric Patients With Vitiligo

The study is an on-line survey posted on survey monkey that addresses some demographic and environmental issues that could potentially relate to vitiligo vulgaris onset or disease exacerbation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Vitiligo Vulgaris Autoimmune Diseases Endocrine System Diseases Hypopigmentation Immune System Diseases Pigmentation Disorders Skin Diseases Skin and Connective Tissue Diseases Thyroid Diseases Vitiligo

Sex eligibility

All sexes

Study type

Observational

Primary location

St. Luke's-Roosevelt Hospital Center

New York, 10025, United States

About this study

The survey is designed to look at some issues that are pertinent to individuals with vitiligo, including access to care, severity of disease, under-reported disease activity, causative and exacerbating factors and co-morbid illnesses.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Ability to complete survey

Exclusion criteria

Inability to complete survey

Treatment and study plan

Primary outcomes

Correlation of Disease State in Vitiligo with Clinical and Psychological Measures

Time frame: Self-reported retrospective single survey

Sponsors and collaborators

Lead sponsor

St. Luke's-Roosevelt Hospital Center

Other

Registry information

Important dates

Study start: 2011
Primary completion: 2016
Study completion: 2016
First posted: Jul 25, 2011
Registry last updated: Apr 10, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed